Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia

NCT00780143 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Poor recruitment

Conditions

Relapsed/Refractory Leukemia

Interventions

DRUG: Plitidepsin plus Cytarabine

Sponsor

PharmaMar